0000946486-19-000001.txt : 20190103 0000946486-19-000001.hdr.sgml : 20190103 20190103170631 ACCESSION NUMBER: 0000946486-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190103 DATE AS OF CHANGE: 20190103 EFFECTIVENESS DATE: 20190103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WINDTREE THERAPEUTICS INC /DE/ CENTRAL INDEX KEY: 0000946486 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943171943 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-329589 FILM NUMBER: 19506720 BUSINESS ADDRESS: STREET 1: 2600 KELLY ROAD STREET 2: SUITE 100 CITY: WARRINGTON STATE: PA ZIP: 18976 BUSINESS PHONE: 2154889300 MAIL ADDRESS: STREET 1: 2600 KELLY ROAD STREET 2: SUITE 100 CITY: WARRINGTON STATE: PA ZIP: 18976 FORMER COMPANY: FORMER CONFORMED NAME: DISCOVERY LABORATORIES INC /DE/ DATE OF NAME CHANGE: 19971201 FORMER COMPANY: FORMER CONFORMED NAME: ANSAN PHARMACEUTICALS INC DATE OF NAME CHANGE: 19961121 FORMER COMPANY: FORMER CONFORMED NAME: ANSAN INC DATE OF NAME CHANGE: 19950609 D 1 primary_doc.xml X0708 D LIVE 0000946486 WINDTREE THERAPEUTICS INC /DE/ 2600 KELLY ROAD SUITE 100 WARRINGTON PA PENNSYLVANIA 18976 2154889300 DELAWARE DISCOVERY LABORATORIES INC /DE/ ANSAN PHARMACEUTICALS INC ANSAN INC Corporation true Craig E. Fraser 2600 Kelly Road Suite 100 Warrington PA PENNSYLVANIA 18976 Executive Officer Director John R. Leone 2600 Kelly Road Suite 100 Warrington PA PENNSYLVANIA 18976 Director Joseph M. Mahady 2600 Kelly Road Suite 100 Warrington PA PENNSYLVANIA 18976 Director Bruce A. Peacock 2600 Kelly Road Suite 100 Warrington PA PENNSYLVANIA 18976 Director James Huang 2600 Kelly Road Suite 100 Warrington PA PENNSYLVANIA 18976 Director Kathryn Cole 2600 Kelly Road Suite 100 Warrington PA PENNSYLVANIA 18976 Executive Officer George Cox 2600 Kelly Road Suite 100 Warrington PA PENNSYLVANIA 18976 Executive Officer Steven A. Simonson 2600 Kelly Road Suite 100 Warrington PA PENNSYLVANIA 18976 Executive Officer John A. Tattory 2600 Kelly Road Suite 100 Warrington PA PENNSYLVANIA 18976 Executive Officer Mary B. Templeton 2600 Kelly Road Suite 100 Warrington PA PENNSYLVANIA 18976 Executive Officer Lawrence A. Weinstein 2600 Kelly Road Suite 100 Warrington PA PENNSYLVANIA 18976 Executive Officer Brian Schreiber 2600 Kelly Road Suite 100 Warrington PA PENNSYLVANIA 18976 Director Biotechnology Decline to Disclose 06b false 2018-12-21 false true true true 0 1000000 1000000 0 false 1 0 0 0 Proceeds will fund activities to transition Istaroxime to phase 3, AEROSURF bridge study activities, Rostafuroxin clinical development, activities related to cardiovascular and KL4 pipeline programs, and general working capital purposes. false WINDTREE THERAPEUTICS INC /DE/ Mary B. Templeton Mary B. Templeton SVP, General Counsel 2019-01-03